Roni Weisshof

1.5k total citations
30 papers, 794 citations indexed

About

Roni Weisshof is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Roni Weisshof has authored 30 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Roni Weisshof's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (12 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Roni Weisshof is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (12 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Roni Weisshof collaborates with scholars based in United States, Israel and Belgium. Roni Weisshof's co-authors include Irit Chermesh, David T. Rubin, Katia El Jurdi, Jacob E. Ollech, Sushila Dalal, Joel Pekow, Atsushi Sakuraba, Russell D. Cohen, Yehuda Chowers and Henit Yanai and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Roni Weisshof

27 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roni Weisshof United States 14 551 376 192 148 116 30 794
Claire E Parker Canada 8 516 0.9× 327 0.9× 159 0.8× 125 0.8× 133 1.1× 11 704
Jesse Siffledeen Canada 13 508 0.9× 445 1.2× 171 0.9× 96 0.6× 169 1.5× 27 809
Azza Filali Tunisia 16 368 0.7× 273 0.7× 277 1.4× 115 0.8× 82 0.7× 106 713
Ray Boyapati Australia 12 410 0.7× 303 0.8× 286 1.5× 233 1.6× 282 2.4× 37 942
Idan Goren Israel 13 407 0.7× 250 0.7× 151 0.8× 142 1.0× 139 1.2× 51 653
P. Cazzola Italy 11 315 0.6× 217 0.6× 236 1.2× 160 1.1× 192 1.7× 16 815
Abdul Elkadri United States 11 536 1.0× 216 0.6× 238 1.2× 396 2.7× 186 1.6× 20 886
Andreas Koutsoumpas United Kingdom 11 215 0.4× 199 0.5× 148 0.8× 95 0.6× 194 1.7× 29 563
A. Massari Italy 14 599 1.1× 481 1.3× 290 1.5× 90 0.6× 47 0.4× 34 921
Abbi R. Saniabadi Japan 16 554 1.0× 367 1.0× 189 1.0× 316 2.1× 68 0.6× 30 842

Countries citing papers authored by Roni Weisshof

Since Specialization
Citations

This map shows the geographic impact of Roni Weisshof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roni Weisshof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roni Weisshof more than expected).

Fields of papers citing papers by Roni Weisshof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roni Weisshof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roni Weisshof. The network helps show where Roni Weisshof may publish in the future.

Co-authorship network of co-authors of Roni Weisshof

This figure shows the co-authorship network connecting the top 25 collaborators of Roni Weisshof. A scholar is included among the top collaborators of Roni Weisshof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roni Weisshof. Roni Weisshof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konikoff, Tom, Henit Yanai, Uri Kopylov, et al.. (2024). Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis. Digestive and Liver Disease. 56(12). 2069–2076.
2.
3.
Haas, Leonard J., Paul Nagy, Mary G. Bowring, et al.. (2023). CHARACTERIZING THE JOHNS HOPKINS INFLAMMATORY BOWEL DISEASE COHORT USING OMOP CDM. Gastroenterology. 164(4). S43–S44.
4.
5.
Korytny, Alexander, et al.. (2023). The Association Between Low Body-Mass Index and Serious Post-endoscopic Adverse Events. Digestive Diseases and Sciences. 68(6). 2180–2187. 1 indexed citations
6.
Albshesh, Ahmad, Piotr Eder, Davide Giuseppe Ribaldone, et al.. (2021). DOP79 Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series. Journal of Crohn s and Colitis. 15(Supplement_1). S111–S111. 1 indexed citations
7.
Albshesh, Ahmad, Piotr Eder, Davide Giuseppe Ribaldone, et al.. (2021). Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series. Journal of Crohn s and Colitis. 16(1). 91–97. 8 indexed citations
8.
Weisshof, Roni, Jacob E. Ollech, Katia El Jurdi, et al.. (2019). Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe. Journal of Crohn s and Colitis. 13(9). 1105–1110. 25 indexed citations
9.
Ungaro, Ryan C., Amit Patel, Parakkal Deepak, et al.. (2019). P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study. Journal of Crohn s and Colitis. 13(Supplement_1). S274–S275. 15 indexed citations
10.
Ollech, Jacob E., Roni Weisshof, Laura Glick, et al.. (2019). Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease. Gastrointestinal Endoscopy. 90(2). 269–275. 35 indexed citations
11.
Weisshof, Roni, Maya Aharoni Golan, Philip H. Sossenheimer, et al.. (2019). Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Digestive Diseases and Sciences. 64(7). 1945–1951. 77 indexed citations
12.
Ollech, Jacob E., David T. Rubin, Laura Glick, et al.. (2019). Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Digestive Diseases and Sciences. 64(12). 3596–3601. 50 indexed citations
13.
Ollech, Jacob E., David T. Rubin, Laura Glick, et al.. (2019). Mo1914 – Ustekinumab is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. Gastroenterology. 156(6). S–884. 2 indexed citations
14.
Weisshof, Roni, et al.. (2018). The Use of Tofacitinib in the Treatment of Inflammatory Bowel Disease. Immunotherapy. 10(10). 837–849. 8 indexed citations
15.
Epstein, Danny, Ilan Merdler, Moran Furman, et al.. (2018). Prevalence of Iron Deficiency and Iron Deficiency Anemia in Strenuously Training Male Army Recruits. Acta Haematologica. 139(3). 141–147. 11 indexed citations
16.
Weisshof, Roni, et al.. (2018). Emerging Therapies for Inflammatory Bowel Disease. Advances in Therapy. 35(11). 1746–1762. 73 indexed citations
17.
Gaujoux, Renaud, Elina Starosvetsky, Francesco Vallania, et al.. (2018). Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD. Gut. 68(4). 604–614. 141 indexed citations
18.
Weisshof, Roni, Bella Ungar, Alexandra Blatt, et al.. (2016). Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(7). 1655–1661. 14 indexed citations
19.
Weisshof, Roni & Irit Chermesh. (2015). Micronutrient deficiencies in inflammatory bowel disease. Current Opinion in Clinical Nutrition & Metabolic Care. 18(6). 576–581. 189 indexed citations
20.
Shlush, Liran I., Gil Atzmon, Roni Weisshof, et al.. (2008). Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J. PLoS ONE. 3(10). e3425–e3425. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire E Parker Breakdown of academic impact, for papers by Jesse Siffledeen Breakdown of academic impact, for papers by Azza Filali Breakdown of academic impact, for papers by Ray Boyapati Breakdown of academic impact, for papers by Idan Goren Breakdown of academic impact, for papers by P. Cazzola Breakdown of academic impact, for papers by Abdul Elkadri Breakdown of academic impact, for papers by Andreas Koutsoumpas Breakdown of academic impact, for papers by A. Massari Breakdown of academic impact, for papers by Abbi R. Saniabadi
Rankless by CCL
2026